Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11ddecc58b66ac371f80bd07b7bdeb8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e25cf8d6dfa3435ccc538114f88123e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fc75547e896df16832cee7e893af33b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2000-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9db1b513238aeaa485f2c47712815a93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5174d2aa4d1e01e633c6045e491e1b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdfccb2660d19e9b3793ae5a31acdc70 |
publicationDate |
2001-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0134792-A2 |
titleOfInvention |
Compositions and methods for the diminution or elimination of various cancers |
abstract |
The present invention relates to the treatment of cancer utilizing Jun Kinase antisense (JNK2AS) mRNA. Additionally, the present invention relates to the screening of reagents that may augment or mimic the effect of JNK2AS treatment for cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009024763-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009024763-A2 |
priorityDate |
1999-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |